Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IMAX
IMAX logo

IMAX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Imax Corp (IMAX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
40.130
1 Day change
3.86%
52 Week Range
43.160
Analysis Updated At
2026/04/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

IMAX Corp is not a strong buy at the moment for a beginner investor with a long-term focus. Despite positive financial growth in revenue and gross margin, the recent decline in net income and EPS, coupled with insider selling and the CEO's medical leave, raises concerns about stability. The lack of strong trading signals and mixed analyst ratings further support a hold decision.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. RSI is at 72.129, which is neutral but approaching overbought levels. Moving averages are converging, suggesting no clear trend. The stock is trading near resistance levels (R2: 40.691), which may limit immediate upside potential.

Options Data

Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • Strong Q4 revenue growth (up 35.11% YoY) and gross margin improvement (up 10.77% YoY). Analysts from Benchmark and B. Riley have raised price targets and maintain buy ratings, citing international expansion and robust system installs.

Neutral/Negative Catalysts

  • CEO's medical leave impacting market confidence. Insider selling has increased significantly (486.11% in the last month). Net income and EPS have dropped sharply (-87.99% and -90.00% YoY, respectively). Mixed analyst ratings with some maintaining neutral positions. Stock trend analysis indicates potential short-term downside (-1.63% in the next week, -4.43% in the next month).

Financial Performance

In Q4 2025, revenue increased by 35.11% YoY to $125.2M, driven by a strong box office and system installs. However, net income dropped by 87.99% YoY to $637K, and EPS fell by 90.00% YoY to $0.01. Gross margin improved to 55.96%, up 10.77% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. Benchmark, B. Riley, and JPMorgan have raised price targets and maintain buy/overweight ratings, citing strong financial performance and strategic growth. However, Goldman Sachs has a neutral rating and recently lowered its price target.

Wall Street analysts forecast IMAX stock price to rise
12 Analyst Rating
Wall Street analysts forecast IMAX stock price to rise
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 38.640
sliders
Low
34
Averages
44
High
47
Current: 38.640
sliders
Low
34
Averages
44
High
47
Goldman Sachs
Stephen Laszczyk
Neutral
downgrade
$720 -> $519
AI Analysis
2026-03-02
Reason
Goldman Sachs
Stephen Laszczyk
Price Target
$720 -> $519
AI Analysis
2026-03-02
downgrade
Neutral
Reason
Goldman Sachs analyst Stephen Laszczyk lowered the firm's price target on Imax to $519 from $720 and keeps a Neutral rating on the shares.
Goldman Sachs
Neutral
maintain
$37 -> $41
2026-03-02
Reason
Goldman Sachs
Price Target
$37 -> $41
2026-03-02
maintain
Neutral
Reason
Goldman Sachs raised the firm's price target on Imax to $41 from $37 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IMAX
Unlock Now

People Also Watch